Mary Rusckowski

4.1k total citations
134 papers, 3.5k citations indexed

About

Mary Rusckowski is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary Rusckowski has authored 134 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Radiology, Nuclear Medicine and Imaging, 55 papers in Molecular Biology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary Rusckowski's work include Radiopharmaceutical Chemistry and Applications (88 papers), Monoclonal and Polyclonal Antibodies Research (46 papers) and Medical Imaging Techniques and Applications (23 papers). Mary Rusckowski is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (88 papers), Monoclonal and Polyclonal Antibodies Research (46 papers) and Medical Imaging Techniques and Applications (23 papers). Mary Rusckowski collaborates with scholars based in United States, China and Japan. Mary Rusckowski's co-authors include Donald J. Hnatowich, D.J. Hnatowich, Guozheng Liu, F. Virzi, Shuping Dou, Suresh Gupta, Jiang He, Fi‐John Chang, G Mardirossian and Miklos C. Fogarasi and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLANT PHYSIOLOGY.

In The Last Decade

Mary Rusckowski

133 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Rusckowski United States 32 2.1k 1.4k 644 441 357 134 3.5k
Ryan J. Park United States 29 1.3k 0.6× 1.2k 0.9× 744 1.2× 277 0.6× 134 0.4× 59 3.0k
Robert Waibel Switzerland 27 1.6k 0.8× 1.2k 0.9× 862 1.3× 349 0.8× 187 0.5× 78 3.0k
Donald J. Hnatowich United States 30 1.4k 0.7× 924 0.7× 386 0.6× 305 0.7× 271 0.8× 99 2.3k
Reingard Senekowitsch–Schmidtke Germany 31 2.3k 1.1× 1.2k 0.9× 826 1.3× 629 1.4× 148 0.4× 84 3.9k
William D. Bloomer United States 32 836 0.4× 658 0.5× 491 0.8× 543 1.2× 398 1.1× 142 3.2k
Agamemnon A. Epenetos United Kingdom 30 1.4k 0.7× 1.1k 0.8× 665 1.0× 250 0.6× 254 0.7× 84 2.5k
Joseph M. Backer United States 31 687 0.3× 1.5k 1.1× 320 0.5× 315 0.7× 181 0.5× 97 2.9k
Franz Buchegger Switzerland 29 1.8k 0.9× 894 0.6× 618 1.0× 632 1.4× 133 0.4× 85 3.1k
Edmund A. Rossi United States 38 2.9k 1.4× 1.4k 1.0× 1.8k 2.8× 530 1.2× 138 0.4× 85 4.3k
Peter Laverman Netherlands 41 2.3k 1.1× 1.6k 1.1× 1.3k 2.0× 676 1.5× 406 1.1× 123 5.2k

Countries citing papers authored by Mary Rusckowski

Since Specialization
Citations

This map shows the geographic impact of Mary Rusckowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Rusckowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Rusckowski more than expected).

Fields of papers citing papers by Mary Rusckowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Rusckowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Rusckowski. The network helps show where Mary Rusckowski may publish in the future.

Co-authorship network of co-authors of Mary Rusckowski

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Rusckowski. A scholar is included among the top collaborators of Mary Rusckowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Rusckowski. Mary Rusckowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riding, Rebecca L., Donna Catalano, Yu‐Jung Lu, et al.. (2022). A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo. Journal of Investigative Dermatology. 142(12). 3294–3303. 10 indexed citations
2.
Dou, Shuping, Miles Smith, Yuzhen Wang, Mary Rusckowski, & Guozheng Liu. (2013). Intraperitoneal Injection Is Not Always a Suitable Alternative to Intravenous Injection for Radiotherapy. Cancer Biotherapy and Radiopharmaceuticals. 28(4). 335–342. 19 indexed citations
3.
Wang, Yuzhen, Ling Chen, Xinrong Liu, et al.. (2012). Detection of Aspergillus fumigatus pulmonary fungal infections in mice with 99mTc-labeled MORF oligomers targeting ribosomal RNA. Nuclear Medicine and Biology. 40(1). 89–96. 34 indexed citations
4.
Hoppin, Jack, et al.. (2011). Assessing Antibody Pharmacokinetics in Mice with In Vivo Imaging. Journal of Pharmacology and Experimental Therapeutics. 337(2). 350–358. 23 indexed citations
5.
Liu, Guozheng, Shuping Dou, Stephen P. Baker, et al.. (2010). A preclinical188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49. Cancer Biology & Therapy. 10(8). 767–774. 16 indexed citations
6.
Liu, Guozheng, Dengfeng Cheng, Shuping Dou, et al.. (2009). Replacing (99m)Tc with (111)In improves MORF/cMORF pretargeting by reducing intestinal accumulation. PubMed Central. 22 indexed citations
7.
Rusckowski, Mary, Suresh Gupta, Guozheng Liu, Shuping Dou, & Donald J. Hnatowich. (2008). Investigation of four 99mTc-labeled bacteriophages for infection-specific imaging. Nuclear Medicine and Biology. 35(4). 433–440. 38 indexed citations
8.
Rusckowski, Mary, Suresh Gupta, Guozheng Liu, Shuping Dou, & Donald J. Hnatowich. (2007). Evidence of Specificity of Radiolabeled Phage Display Peptides for the TAG-72 Antigen. Cancer Biotherapy and Radiopharmaceuticals. 22(4). 564–572. 14 indexed citations
9.
He, Jiang, Mary Rusckowski, Yi Wang, et al.. (2006). Optical Pretargeting of Tumor with Fluorescent MORF Oligomers. Molecular Imaging and Biology. 9(1). 17–23. 9 indexed citations
10.
He, Jiang, Guozheng Liu, Surong Zhang, Mary Rusckowski, & Donald J. Hnatowich. (2003). Pharmacokinetics In Mice of Four Oligomer-Conjugated Polymers for Amplification Targeting. Cancer Biotherapy and Radiopharmaceuticals. 18(6). 941–947. 10 indexed citations
11.
He, Jiang, et al.. (2003). Investigations of 99mTc morpholino pretargeting in mice. Nuclear Medicine Communications. 24(6). 697–705. 27 indexed citations
12.
Su, Zi-Fen, Jiang He, Mary Rusckowski, & Donald J. Hnatowich. (2003). In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands. Nuclear Medicine and Biology. 30(2). 141–149. 30 indexed citations
13.
Liu, Guozheng, Charles R. Wescott, Aaron K. Sato, et al.. (2002). Nitriles form mixed-coligand complexes with 99mTc-HYNIC-Peptide. Nuclear Medicine and Biology. 29(1). 107–113. 12 indexed citations
14.
Zhang, Yumin, Mary Rusckowski, Ning Liu, Changbin Liu, & Donald J. Hnatowich. (2001). Cationic Liposomes Enhance Cellular/Nuclear Localization of 99m Tc-Antisense Oligonucleotides in Target Tumor Cells. Cancer Biotherapy and Radiopharmaceuticals. 16(5). 411–419. 28 indexed citations
15.
Wang, Yuanqing, et al.. (2001). Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm. Nuclear Medicine Communications. 22(2). 203–215. 37 indexed citations
16.
Rusckowski, Mary, Miklos C. Fogarasi, B A Fritz, & Donald J. Hnatowich. (1997). Effect of endogenous biotin on the applications of streptavidin and biotin in mice. Nuclear Medicine and Biology. 24(3). 263–268. 31 indexed citations
17.
Virzi, F., Paul Winnard, Miklos C. Fogarasi, et al.. (1995). Recombinant Metallothionein-Conjugated Streptavidin Labeled with 188Re and 99mTc. Bioconjugate Chemistry. 6(1). 139–144. 7 indexed citations
18.
Virzi, F., et al.. (1991). New indium-111 labeled biotin derivatives for improved immunotargeting. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(7). 719–726. 11 indexed citations
19.
Rusckowski, Mary, et al.. (1984). Production and Partial Purification of Rat Fibroblast-Derived Interferon Induced in a Newly Established Cell Line. Journal of Interferon Research. 4(3). 365–374. 6 indexed citations
20.
Rusckowski, Mary, et al.. (1982). Chemical Modification of Mouse Interferons. Journal of Interferon Research. 2(2). 177–185. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan J. Park Breakdown of academic impact, for papers by Robert Waibel Breakdown of academic impact, for papers by Donald J. Hnatowich Breakdown of academic impact, for papers by Reingard Senekowitsch–Schmidtke Breakdown of academic impact, for papers by William D. Bloomer Breakdown of academic impact, for papers by Agamemnon A. Epenetos Breakdown of academic impact, for papers by Joseph M. Backer Breakdown of academic impact, for papers by Franz Buchegger Breakdown of academic impact, for papers by Edmund A. Rossi Breakdown of academic impact, for papers by Peter Laverman
Rankless by CCL
2026